Showing results (301-310 of 735) with videos related to

Sort By:
Pageof 74
British Journal of Haematology|November 1, 1986
Ex vivo T-cell depletion with the monoclonal antibody Campath-1 plus human complement effectively prevents acute graft-versus-host disease in allogeneic bone marrow transplantationW Heit, D Bunjes, M Wiesneth, et al.
Clinical and Experimental Immunology|December 1, 1996
A therapeutic human IgG4 monoclonal antibody that depletes target cells in humansJ D Isaacs, M G Wing, J D Greenwood, et al.
The Journal of Antimicrobial Chemotherapy|July 1, 1997
Comparison of the in-vitro and in-vivo efficacy of FK037, vancomycin, imipenem and nafcillin against staphylococcal speciesM W Climo, S M Markowitz, D S Williams, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 1, 2008
Cellular immune reconstitution after haploidentical transplantation in childrenR Handgretinger, X Chen, M Pfeiffer, et al.
Journal of Medical Genetics|December 14, 1999
Neocentromere formation in a stable ring 1p32-p36.1 chromosomeH R Slater, S Nouri, E Earle, et al.
Human Reproduction (Oxford, England)|September 10, 2013
First reported clinical pregnancy following heterotopic grafting of cryopreserved ovarian tissue in a woman after a bilateral oophorectomyC J Stern, D Gook, L G Hale, et al.
Cureus|July 24, 2023
A Case of Oxalate Nephropathy Associated With Prolonged Cholecystostomy Tube PlacementAmanda G Hale, Derek S Anderson, Tara Eineichner, et al.
Cell Reports|March 23, 2022
Restriction factor screening identifies RABGAP1L-mediated disruption of endocytosis as a host antiviral defenseSonja Fernbach, Eva E Spieler, Idoia Busnadiego, et al.
Eye (London, England)|January 1, 1995
Prevention of immune-mediated corneal graft destruction with the anti-lymphocyte monoclonal antibody, CAMPATH-1HD K Newman, J D Isaacs, P G Watson, et al.
Leukemia & Lymphoma|May 1, 1997
Autologous transplantation with CD52 monoclonal antibody-purged marrow for acute lymphoblastic leukemia: long-term follow-upJ Mehta, R Powles, J Treleaven, et al.
Pageof 74